Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Tanaka Medical Clinic, Yoichi, Japan.
Hypertens Res. 2023 Dec;46(12):2635-2645. doi: 10.1038/s41440-023-01392-x. Epub 2023 Aug 2.
A disorder of lipid metabolism is involved in cardiovascular diseases including hypertension. A high level of small dense low-density lipoprotein cholesterol (sdLDL-C) is a strong risk factor for atherosclerotic cardiovascular disease. However, the association between sdLDL-C and hypertension has not been fully investigated. We investigated the associations between the development of hypertension during a 10-year period and levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-HDL-C, triglycerides (TG), and LDL-C and sdLDL-C calculated by using the Sampson equations in 28,990 Japanese subjects who received annual health examinations. After exclusion of subjects with missing data, those with hypertension, and those with TG ≥ 800 mg/dL at baseline, a total of 15,177 subjects (men/women: 9374/5803, mean age: 46 years) were recruited. During the 10-year period, 2379 men (25.4%) and 724 women (12.5%) had new onset of hypertension. Multivariable Cox proportional hazard model analyses showed that levels of HDL-C, non-HDL-C, TG and sdLDL-C, but not levels of TC and LDL-C, were independent risk factors for the development of hypertension after adjustment of age, sex, family history of hypertension, systolic blood pressure, obesity, current smoking habit, alcohol drinking habit, estimated glomerular filtration rate, diagnosis of diabetes mellitus and use of lipid-lowering drugs and that the adjusted risk of sdLDL-C (per 1-standard deviation) was highest (hazard ratio [95% confidence interval: 1.09 [1.05-1.13]). The addition of sdLDL-C to traditional risk factors for hypertension significantly improved the discriminatory capability, which was better than that of other lipid fractions. In conclusion, a high level of calculated sdLDL-C predicts the development of hypertension.
脂代谢紊乱与包括高血压在内的心血管疾病有关。小而密的低密度脂蛋白胆固醇(sdLDL-C)水平升高是动脉粥样硬化性心血管疾病的一个强烈危险因素。然而,sdLDL-C 与高血压之间的关系尚未得到充分研究。我们调查了在 10 年内发展为高血压的患者与接受年度体检的 28990 名日本受试者中总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、非高密度脂蛋白胆固醇(non-HDL-C)、甘油三酯(TG)和 LDL-C 及用 Sampson 方程计算的 sdLDL-C 水平之间的关系。排除有缺失数据、高血压和基线 TG≥800mg/dL 的患者后,共纳入 15177 名受试者(男性/女性:9374/5803,平均年龄:46 岁)。在 10 年内,2379 名男性(25.4%)和 724 名女性(12.5%)出现新发高血压。多变量 Cox 比例风险模型分析显示,在调整年龄、性别、高血压家族史、收缩压、肥胖、当前吸烟习惯、饮酒习惯、估算肾小球滤过率、糖尿病诊断和使用降脂药物后,HDL-C、non-HDL-C、TG 和 sdLDL-C 水平是高血压发生的独立危险因素,但 TC 和 LDL-C 水平不是。sdLDL-C(每 1 个标准差)的调整风险最高(危险比[95%置信区间:1.09[1.05-1.13])。将 sdLDL-C 添加到高血压的传统危险因素中显著提高了区分能力,优于其他脂质成分。总之,高水平的计算 sdLDL-C 可预测高血压的发生。